Modulation/NN
of/IN
the/DT
expression/NN
of/IN
the/DT
IFN-gamma/NN
receptor/NN
beta-chain/NN
controls/VBZ
responsiveness/NN
to/TO
IFN-gamma/NN
in/IN
human/JJ
peripheral/JJ
blood/NN
T/NN
cells/NNS
./.

IFN-gamma/NN
has/VBZ
potent/JJ
antiproliferative/JJ
and/CC
apoptotic/JJ
effects/NNS
in/IN
T/NN
cells/NNS
that/WDT
are/VBP
important/JJ
in/IN
determining/VBG
T/NN
cell/NN
development/NN
and/CC
polarized/VBN
differentiation/NN
./.
=====
Therefore/RB
,/,
any/DT
event/NN
that/WDT
enables/VBZ
T/NN
cells/NNS
to/TO
become/VB
less/RBR
responsive/JJ
to/TO
IFN- gamma/NN
may/MD
potentially/RB
alter/VB
immune/JJ
responsiveness/NN
to/TO
Ag/NN
./.
=====
In/IN
this/DT
work/NN
,/,
we/PRP
show/VBP
that/IN
human/JJ
peripheral/JJ
blood/NN
T/NN
cells/NNS
that/WDT
are/VBP
stimulated/VBN
through/IN
the/DT
TCR/NN
and/CC
expanded/VBN
with/IN
IL-2/NN
are/VBP
unresponsive/JJ
to/TO
IFN-gamma/NN
,/,
as/IN
determined/VBN
by/IN
a/DT
lack/NN
of/IN
activation/NN
of/IN
jak/NN
kinases/NNS
and/CC
the/DT
transcription/NN
factor/NN
,/,
STAT1/NN
(/(
alpha/NN
)/)
,/,
a/DT
signal/NN
transducer/NN
and/CC
activator/NN
of/IN
transcription/NN
./.
=====
This/DT
nonresponsiveness/NN
occurs/VBZ
because/IN
of/IN
a/DT
lack/NN
of/IN
expression/NN
of/IN
the/DT
beta- chain/NN
(/(
accessory/JJ
factor/NN
)/)
of/IN
the/DT
IFN-gamma/NN
receptor/NN
,/,
while/IN
at/IN
the/DT
same/JJ
time/NN
maintaining/VBG
IFN-gamma/NN
receptor/NN
alpha-chain/NN
expression/NN
./.
=====
Expression/NN
of/IN
the/DT
beta-chain/NN
can/MD
be/VB
restored/VBN
by/IN
secondary/JJ
TCR/NN
ligation/NN
or/CC
PMA/NN
treatment/NN
./.
=====
T/NN
cell/NN
blasts/NNS
treated/VBN
with/IN
PMA/NNS
are/VBP
now/RB
responsive/JJ
to/TO
IFN-gamma/NN
./.
=====
When/WRB
freshly/RB
isolated/VBN
,/,
highly/RB
enriched/VBN|JJ
(/(
>/JJR
98/CD
%/NN
)/)
T/NN
cells/NNS
are/VBP
examined/VBN
for/IN
IFN-gamma/NN
responsiveness/NN
;/:
these/DT
cells/NNS
can/MD
respond/VB
to/TO
IFN-gamma/NN
and/CC
express/VB
beta-chain/NN
./.
=====
Therefore/RB
,/,
as/IN
T/NN
cells/NNS
progress/VBP
from/IN
primary/JJ
TCR/NN
activation/NN
through/IN
IL-2-dependent/JJ
proliferation/NN
,/,
followed/VBN
by/IN
secondary/JJ
TCR/NN
stimulation/NN
,/,
their/PRP$
responsiveness/NN
to/TO
IFN-gamma/NN
varies/VBZ
,/,
and/CC
this/DT
may/MD
affect/VB
their/PRP$
ability/NN
to/TO
participate/VB
in/IN
an/DT
ongoing/JJ
immune/JJ
response/NN
./.